<- Go Home
Provexis plc
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through e-commerce website and distributors. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
Market Cap
GBP 29.6M
Volume
902.5K
Cash and Equivalents
GBP 523.3K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
GBP 429.0K
Profit Margin
49.24%
52 Week High
GBP 0.02
52 Week Low
GBP 0.01
Dividend
N/A
Price / Book Value
25.87
Price / Earnings
-48.28
Price / Tangible Book Value
25.87
Enterprise Value
GBP 28.5M
Enterprise Value / EBITDA
N/A
Operating Income
-GBP 614.2K
Return on Equity
125.49%
Return on Assets
-46.13
Cash and Short Term Investments
GBP 523.3K
Debt
N/A
Equity
GBP 610.9K
Revenue
GBP 871.3K
Unlevered FCF
-GBP 324.4K
Sector
Personal Care Products
Category
N/A